Blackstone to Exit from Alinamin Pharmaceutical
02 Jul 2024
US$ 19.00
Blackstone Inc is to sell its stake in Alinamin Pharmaceutical Co Ltd (Alinamin Pharmaceutical) to MBK Partners for ¥...
Related Publications
Norwest has led the 1.2 bn rupees (US$12.5 m) funding round in Rezolv AI Technology Solutions Pvt Ltd (Rezolv), joined...
Tata Capital Healthcare Fund, through its Fund III, along with Switzerland-based Blue Earth Capital AG, have invested...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.